Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Chi

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Developmental and Comparative Immunology|January 1, 1982
Transfer of delayed hypersensitivity in the chickenD S Chi, M A Palladino, T Romano, et al.
International Journal of Immunopharmacology|July 1, 1992
Effects of MPTP and vitamin E treatments on immune function in miceD S Chi, L Gong, E A Daigneault, et al.
Gynecologic Oncology|April 29, 2000
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinomaD S Chi, E S Venkatraman, V Masson, et al.
Gynecologic Oncology|November 5, 1997
The role of surgical cytoreduction in Stage IV endometrial carcinomaD S Chi, M Welshinger, E S Venkatraman, et al.
Molecular Immunology|July 1, 1981
Characterization of avian lymphocyte surface proteins which bind to membrane and circulating immunoglobulinsR E Cone, D S Chi, M D Grebenau, et al.
The American Journal of Gastroenterology|December 17, 1997
The role of the oral cavity in Helicobacter pylori infectionE Thomas, C Jiang, D S Chi, et al.
Gynecologic Oncology|March 2, 2010
Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated seriesK K Shih, D S Chi, R R Barakat, et al.
Psychosomatic Medicine|September 1, 1992
Effects of stress and blood type on cortisol and VLDL toxicity preventing activityJ K Neumann, B W Arbogast, D S Chi, et al.
Gynecologic Oncology|November 10, 2009
Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancerK K Shih, D S Chi, R R Barakat, et al.
European Journal of Gynaecological Oncology|September 4, 1999
Primary intravenous paclitaxel and platinum chemotherapy for high-risk Stage I epithelial ovarian carcinomaD S Chi, R J Waltzman, R R Barakat, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Developmental and Comparative Immunology|January 1, 1982
Transfer of delayed hypersensitivity in the chickenD S Chi, M A Palladino, T Romano, et al.
International Journal of Immunopharmacology|July 1, 1992
Effects of MPTP and vitamin E treatments on immune function in miceD S Chi, L Gong, E A Daigneault, et al.
Gynecologic Oncology|April 29, 2000
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinomaD S Chi, E S Venkatraman, V Masson, et al.
Gynecologic Oncology|November 5, 1997
The role of surgical cytoreduction in Stage IV endometrial carcinomaD S Chi, M Welshinger, E S Venkatraman, et al.
Molecular Immunology|July 1, 1981
Characterization of avian lymphocyte surface proteins which bind to membrane and circulating immunoglobulinsR E Cone, D S Chi, M D Grebenau, et al.
The American Journal of Gastroenterology|December 17, 1997
The role of the oral cavity in Helicobacter pylori infectionE Thomas, C Jiang, D S Chi, et al.
Gynecologic Oncology|March 2, 2010
Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated seriesK K Shih, D S Chi, R R Barakat, et al.
Psychosomatic Medicine|September 1, 1992
Effects of stress and blood type on cortisol and VLDL toxicity preventing activityJ K Neumann, B W Arbogast, D S Chi, et al.
Gynecologic Oncology|November 10, 2009
Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancerK K Shih, D S Chi, R R Barakat, et al.
European Journal of Gynaecological Oncology|September 4, 1999
Primary intravenous paclitaxel and platinum chemotherapy for high-risk Stage I epithelial ovarian carcinomaD S Chi, R J Waltzman, R R Barakat, et al.
Pageof 11